Clinical Trial Update: Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED)

View source ↗

Summary

A post-marketing surveillance study of children with chronic hepatitis C treated with Intron A (interferon alfa-2b) and Rebetol (ribavirin) under Study P04397 h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Intron A (interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Hepatitis C | Status: TERMINATED